Elevated α-synuclein levels inhibit mitophagic flux
Open Access
- 9 April 2024
- journal article
- research article
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-15
Abstract
The pathogenic effect of SNCA gene multiplications indicates that elevation of wild-type α-synuclein levels is sufficient to cause Parkinson’s disease (PD). Mitochondria have been proposed to be a major target of α-synuclein-induced damage. PINK1/parkin/DJ-1-mediated mitophagy is a defense strategy that allows cells to selectively eliminate severely damaged mitochondria. Here, we quantified mitophagic flux and non-mitochondrial autophagic flux in three models of increased α-synuclein expression: 1/Drosophila melanogaster that transgenically express human wild-type and mutant α-synuclein in flight muscle; 2/human skin fibroblasts transfected with α-synuclein or β-synuclein; and 3/human induced pluripotent stem cell (iPSC)-derived neurons carrying an extra copy of wild-type SNCA under control of a doxycycline-inducible promoter, allowing titratable α-synuclein upregulation. In each model, elevated α-synuclein levels potently suppressed mitophagic flux, while non-mitochondrial autophagy was preserved. In human neurons, a twofold increase in wild-type α-synuclein was already sufficient to induce this effect. PINK1 and parkin activation and mitochondrial translocation of DJ-1 after mitochondrial depolarization were not affected by α-synuclein upregulation. Overexpression of the actin-severing protein cofilin or treatment with CK666, an inhibitor of the actin-related protein 2/3 (Arp2/3) complex, rescued mitophagy in neurons with increased α-synuclein, suggesting that excessive actin network stabilization mediated the mitophagy defect. In conclusion, elevated α-synuclein levels inhibit mitophagic flux. Disruption of actin dynamics may play a key role in this effect.Keywords
Funding Information
- KU Leuven
- Fonds Wetenschappelijk Onderzoek
- European Molecular Biology Organization
This publication has 61 references indexed in Scilit:
- CRISPR/Cas9 screen in human iPSC‐derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicityAlzheimer's & Dementia, 2022
- SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human SystemStem Cell Reviews and Reports, 2021
- PPEF2 Opposes PINK1-Mediated Mitochondrial Quality Control by Dephosphorylating UbiquitinCell Reports, 2019
- Prdm12 Directs Nociceptive Sensory Neuron Development by Regulating the Expression of the NGF Receptor TrkACell Reports, 2019
- Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsActa Neuropathologica, 2018
- α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP productionActa Neuropathologica, 2017
- Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical ResearchCell Reports, 2015
- Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- α-Synuclein Gene Rearrangements in Dominantly Inherited ParkinsonismArchives of Neurology, 2009
- Genomic investigation of α‐synuclein multiplication and parkinsonismAnnals of Neurology, 2008